11-63373661-T-A
Variant summary
Our verdict is Likely pathogenic. The variant received 6 ACMG points: 6P and 0B. PM2PP3_Strong
The NM_080866.3(SLC22A9):c.524T>A(p.Val175Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_080866.3 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC22A9 | NM_080866.3 | c.524T>A | p.Val175Glu | missense_variant | Exon 3 of 10 | ENST00000279178.4 | NP_543142.2 | |
SLC22A9 | XM_017017159.3 | c.524T>A | p.Val175Glu | missense_variant | Exon 3 of 8 | XP_016872648.1 | ||
SLC22A9 | XM_047426335.1 | c.-32-233T>A | intron_variant | Intron 1 of 7 | XP_047282291.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.524T>A (p.V175E) alteration is located in exon 3 (coding exon 3) of the SLC22A9 gene. This alteration results from a T to A substitution at nucleotide position 524, causing the valine (V) at amino acid position 175 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at